Psychoneuroimmunology: Elucidating the process

Current Opinion in Psychiatry

Volumn 9, Issue 6, 1996, Pages 427-432

  O'Leary, Ann ^a   Savard, Josée ^b   Miller, Suzanne M ^b  

^a RUTGERS UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC ACTIVITY; DEPRESSION; MENTAL STRESS; NEUROIMMUNOLOGY; PERSONALITY; PSYCHOLOGICAL ASPECT; PSYCHOPHYSIOLOGY; SEROTONINERGIC SYSTEM; SHORT SURVEY;

EID: 0029806117     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-199611000-00012     Document Type: Short Survey

References (46)

1. O'Leary A: Stress, emotion, and human immune function. Psychol Bull 1990; 108:363-382.
2. Herbert TB, Cohen S: Depression and immunity: a meta-analytic review. Psychol Bull 1993; 113:472-486.
3. Herbert TB, Cohen S: Stress and immunity in humans: a meta-analytic review. Psychosom Med 1993; 55:364-379.
4. O'Leary A, Miller SM: Stress, emotion, and human immune function. Clin Immunol Newsletter 1991; 11:177-182.
5. O'Leary A, Brown S, Swarez-AI-Adam M: Stress and human immune function. In Clinical disorders and stressful life events Edited by Miller TW. New York: International Universities Press; 1996:181-215.
6. Wiedenfeld S, O'Leary A, Bandura A, Brown S, Levine S, Raska K: Impact of perceived self-efficacy in coping with Stressors on components of the immune system. J Pers Soc Psychol 1990; 59:1082-1094.
7. Kiecolt-Glaser JK, Cacioppo JT, Malarkey WB, Glaser R: Acute psychological Stressors and short-term immune changes: what, why, for whom, and to what extent? Psychosom Med 1992; 54:680-685.
8. Locke S, Kraus L, Kutz I, Edbrie S, Phillips K, Benson H: Altered natural killer cell activity during norepinephrine infusion in humans. Proceedings of the First International Workshop on Neuroimmunomodulation. New York: Gordon and Breach; 1984:297.
9. Delahanty DL, Dougall AL, Hawken L, Trakowski JH, Schmitz JB, Jenkins FJ, Baum A: Time course of natural killer cell activity and lymphocyte proliferation in response to two acute stressors in healthy men. Health Psychol 1996; 15:48-55. Thirty-one healthy men participated in this study. One particularly interesting feature was the inclusion of two additional assessment time points, 5 and 15 min after the end of the stressful task, as well as the usual assessment time points before, during, and immediately after the task. This procedure allowed the authors to observe that the NK activity response to acute stress may be curvilinear and characterized by a significant increase immediately after the stressor termination followed by a marginally significant decrease comparatively to baseline values. Besides, higher heart rate and blood pressure were found to predict increases in NK cell cytotoxicity, as well as reduced proliferative response to concanavalin A, but not to pokeweed mitogen.
10. Bachen EA, Manuck SB, Cohen S, Muldoon MF, Raible R, Herbert TB, Rabin BS: Adrenergic blockade ameliorates cellular immune responses to mental stress in humans. Psychosom Med 1995; 57:366-372.
11. Matthews KA, Caggiula AR, McAllister CG, Berga SL, Owens JF, Flory JD, Miller AL: Sympathetic reactivity to acute stress and immune response in women. Psychosom Med 1995; 57:564-571.
12. Marsland AL, Manuck SB, Fazzari TV, Stewart CJ, Rabin BS: Stability of individual differences in cellular immune responses to acute psychological stress. Psychosom Med 1995; 57:295-298. This study was conducted in 30 healthy participants who participated in two speech tasks separated by a 2-week interval. Across the two sessions, a significant decline in B-cell number and a proliferative response to PHA, as well as a significant increment in T-suppressor/cytotoxic cells and in CD56 cell count, were observed with the administration of the stressful task. More importantly, test-retest correlations computed on immune changes at both time points revealed a significant association of a high magnitude for heart rate and blood pressure rate, and of a moderate magnitude for proliferative response to PHA (but not to concanavalin) and for the number of circulating T-cells, T-suppressor/ cytotoxic cells, and CD56 cells. These results support the stability of individual differences in immune functioning.
13. Mills PJ, Dimsdale JE, Nelesen RA, Dillon E: Psychologic characteristics associated with acute stressor-induced leukocyte subset redistribution. J Psychosom Res 1996; 40:417-423.
14. Buss A, Durkee A: An inventory for assessing different kinds of hostility. J Consult Psychol 1957; 21:343-349.
15. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401.
16. Spielberger CD, Johnson E, Russell S, Crane R, Jacobs G, Worden T: Manual for the State-Trait Anxiety Inventory (STAI Form Y). In Anger and hostility in cardiovascular and behavioural disorders Palo Alto: Consulting Psychologists Press; 1983.
17. La Via MF, Munno I, Lydiard RB, Workman EW, Hubbard JR, Michel Y, Paulling E: The influence of stress intrusion on immunodepression in generalized anxiety disorder patients and controls. Psychosom Med 1996; 58:138-142.
18. Miller SM, Shoda Y, Hurley K: Applying cognitive-social theory to health-protective behavior: breast self-examination in cancer screening. Psychol Bull 1996; 119:70-94.
19. Miller SM, Mischel W, O'Leary A, Mills M: From human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control. Ann Behav Med 1996 (In press).
20. Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41209-218.
21. Pennebaker JW, Kiecolt-Glaser JK, Glaser R: Disclosure of traumas and immune function: health implications for psychotherapy. J Consult Clin Psychol 1988; 56:239-245.
22. Petrie KJ, Booth RJ, Pennebaker JW, Davison KP, Thomas MG: Disclosure of trauma and immune response to a hepatitis B vaccination program. J Consult Clin Psychol 1995; 63:787-792. This is the only study published this year to evaluate the clinical significance of immune alterations associated with psychological factors. Forty medical students participated in this study. Participants were randomly assigned to a foursession writing emotional expression intervention ('the most traumatic and upsetting experiences of your whole life') or a control condition, after which they received the first of their three hepatitis B vaccination. Although the results obtained when including participants with pre-existing levels of anti-hepatitis B antibodies were included are less convincing, the authors suggested that expression of traumatic experiences can have significant health consequences.
23. Christensen AJ, Edwards DL, Wiebe JS, Benotsch EG, McKelvey L, Andrews M, Lubaroff DM: Effect of self-disclosure on natural killer cell activity: moderating influence of cynical hostility. Psychosom Med 1996; 58:150-155.
24. Maes M, Smith R, Scharpe S: The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995; 20:111-116.
25. Bauer ME, Gauer GJ, Luz C, Silveira RO, Nardi NB, von Mühlen CA: Evaluation of immune parameters in depressed patients. Life Sci 1995, 57:665-674. Some demographic data and health behaviors may have an impact on immunity. Aware of these potentially confounding factors, the authors generally controlled for them when performing their statistical analyses. In this article, the authors relied on a more rigorous approach by pairing the depressed patients with identical control participants on the following variables: gender, age (with a range limit of 5 years), race, physical activity, socioeconomical levels, tobacco, and contraceptive use. Although this approach is certainly restricting, we can more confidently conclude whether the differences observed on immune functioning are related to depression or not.
26. Barden N, Reul JMHM, Holsboer F: Do antidepressants stabilize mood through actions on hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995; 18:6-11.
27. Kook AI, Mizruchin A, Odnopozov N, Gershon H, Segev Y: Depression and immunity: the biochemical interrelationship between the central nervous system and the immune system. Biol Psychiatry 1995; 37:817-819.
28. Ravindran AV, Griffiths J, Merali Z, Anisman H: Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment. Psychosom Med 1995; 57:555-563.
29. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affective Drsord 1995; 34:301-309.
30. Uchino BN, Cacioppo JT, Kiecolt-Glaser JK: The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull 1996; 119:488-531. This is an outstanding and comprehensive literature review covering the relationship between social support and the cardiovascular, endocrine, and immune systems. The authors describe the data qualitatively as well as quantitatively. Indeed, meta-analyses were performed when the number of similar studies was sufficient. An excellent discussion examining the potential mechanisms linking social support to physiological functioning follows.
31. + cells count. Therefore, it is suggested that researchers should include functional measures of immunity in their future investigations rather than only rely on enumerative measures.
32. Mierlak D, Leon A, Perry S: Does physical improvement reduce depressive symptoms in HIV-infected medical inpatients? Gen Hosp Psychiatry 1995; 17:380-384.
33. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571.
34. Patterson TL, Semple SJ, Temoshok LR, Atkinson JH, McCutchan JA, Straits-Tröster K, Chandler JL, Grant I, and the HIV Neurobehavioral Research Center Group: Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. Psychiatry 1995; 58:299-312.
35. Brown GW, Harris TO: London: Social origins of depression. In A study of psychiatric disorders in women London: Tavistock; 1978.
36. Hamilton MA: A rating scale for depression. J Neurol Psychiatry 1960; 23: 56-62.
37. Goodkin K, Mulder CL, Blaney NT, Kumar M, Fletcher MA: Psychoneuroimmunology and human immunodeficiency virus type 1 infection revisited [letter to the editor]. Arch Gen Psychiatry 1994; 51:246-247.
38. Mulder CL, Antoni MH, Duivenvoorden HJ, Kauffmann RH, Goodkin K: Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men. J Psychosom Res 1995; 39:957-965.
39. Sarason IG, Johnson JH, Siegel JM: Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol 1978; 46:932-946.
40. Kemeny ME, Weiner H, Duran R, Taylor SE, Visscher B, Fahey JL: Immune system changes after the death of a partner in HIV-positive gay men. Psychosom Med 1995; 57:547-554. A particularly interesting and relevant empirical question was tested in this study. Indeed, many HIV-seropositive patients have to face the death of their intimate partner and bereavement has been found to be related to immune changes. The longitudinal design of the study is another positive aspect.
41. Eller LS: Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV. Ann Behav Med 1995; 17:339-348.
42. Markowitz JC, Klerman GL, Clougherty KF, Spielman LA, Jacobsberg LB, Fishman B, Frances AJ, Kocsis JH, Perry III SW: Individual psychotherapies for depressed HIV-positive patients. Am J Psychiatry 1995; 152: 1504-1509.
43. Andersen BL, Kiecolt-Glaser JK, Glaser R: A biobehavioral model of cancer stress and disease course. Am Psychol 1994; 49:389-404.
44. Contrada RJ, Leventhal H, O'Leary A: Personality and health. In Handbook of personality: theory & research Edited by Pervin LA. New York: Guilford Press; 1990:638-669.
45. Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, Salonen JT: Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med 1996; 58:113-121.
46. Sachs G, Rasoul-Rockenschaub S, Aschauer H, Spiess K, Göber I, Staffen A, Zielinsk C: Lytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study. J Neuroimmunol 1995; 59:83-89